biographies

Professor Colin Cooper
Dr. David Dearnaley
Dr. Ros Eeles
Professor Alan Horwich
Dr Robert Huddart
Ms Clare Moynihan
Dr Janet Shipley
Professor Mike Stratton

Note: Members of the press can download high-resolution JPEGs of these scientists from our photo library.

Professor Colin Cooper

Professor Colin Cooper is Chairman of the Section of Molecular Carcinogenesis and Head of the Haddow Laboratories at The Institute of Cancer Research - a department which he established in 1989. He has a special interest in molecular genetics. As a result of the work of his department, The Institute of Cancer Research is responsible for the discovery of more cancer-related genes than any other organisation in the world. Professor Cooper is a male cancers specialist and will direct the UK's first dedicated research centre for urological cancers, the everyman centre, funded by The Institute's everyman campaign.

Dr David Dearnaley

A Senior Lecturer and Consultant at The Institute of Cancer Research and Royal Marsden Hospital, Dr David Dearnaley specialises in prostate, testicular and bladder cancer and heads the Urology Unit at the Royal Marsden. Current projects include the development of conformal and other techniques to improve radical radiotherapy - both by increasing tumour control and by reducing side effects from treatment. Dr Dearnaley is also researching the genetics of prostate cancer treatment and hormone refractory treatment of prostate cancer. A major challenge is to diagnose prostate cancer early and to find out which of these early cancers need aggressive treatment.

Dr Ros Eeles

Dr Ros Eeles is a Senior Lecturer at The Institute of Cancer Research. She runs the UK's biggest study into familial prostate cancer which aims to find the cause of the disease and develop new methods of early detection and prevention, and other research programmes into genetic predisposition to breast cancer and childhood cancers. Dr Eeles is a clinician as well as a scientist, and is very knowledgeable about cancer generally, especially prostate and breast.

Professor Alan Horwich

Professor Alan Horwich has been Director of Clinical Research and Development at The Institute of Cancer Research and Royal Marsden NHS Trust since 1994. He is a specialist in male cancers and involved in research into both chemotherapy and radiotherapy. His team is responsible for the non-surgical oncology of testicular, prostate and bladder cancers and lymphomas. Professor Horwich is also Chairman of the Section of Radiotherapy at The Institute of Cancer Research. The section has particular responsibility for translating the results of radiobiological research into clinical practice. Professor Horwich initiated plans for the UK's first dedicated research centre for urological cancers (the everyman centre) at The Institute of Cancer Research, which is to be funded by the proceeds of The Institute's everyman campaign.

Dr Robert Huddart
Dr Robert Huddart is Senior Lecturer and Honorary Consultant in Radiotherapy and Oncology at The Institute of Cancer Research and the Royal Marsden Hospital NHS Trust. He is currently researching prostate and bladder cancers and specialises in the treatment and genetics of testicular cancer.

Ms Clare Moynihan
Ms Moynihan is a medical sociologist at The Institute of Cancer Research in Sutton. She is running various studies involving interviewing men about prostate and testicular cancer so that health workers are better prepared to offer counselling and information as scientific knowledge increases.

Dr Janet Shipley
Dr Janet Shipley is a Team Leader in the Section of Molecular Carcinogenesis at The Institute of Cancer Research. The major aim of her team is to identify which genes are involved in the development and progression of particular types of tumour including testicular germ cell tumours.

Professor Mike Stratton
Professor Mike Stratton is Chairman of the Section of Cancer Genetics at The Institute of Cancer Research. Professor Stratton was responsible for discovering BRCA2, one of the two genes known to predispose women to breast cancer. He is a specialist in the genetic research of a broad spectrum of cancers, including testicular cancer.